Repeat cervical cytology at the time of colposcopy. Is there an added benefit?

Acta Cytol. 2001 Jan-Feb;45(1):23-7. doi: 10.1159/000327183.

Abstract

Objective: To determine if repeating the Pap smear (PS) at colposcopy offers added benefit in the detection of cervical squamous intraepithelial lesions (SILs).

Study design: Eight hundred fifty-two women were subjects of this study. Patients with cervical SIL were defined as women with SIL on the repeat PS, or SIL on the colposcopic cervical biopsy (bx) or a negative repeat PS and bx but confirmed SIL on both the previous and follow-up PS or bx. The sensitivities of repeat PS and bx in detecting SIL were calculated. The chi 2 test was used to assess statistical significance. The total cost of repeating the PS was calculated by multiplying the total number of patients (852) by the estimated cost of a single PS ($25).

Results: The sensitivities of repeat PS, bx and PS/bx combined were .89, .69 and .92 for low grade SIL (LSIL) and .74, .77 and .98 for high grade SIL (HSIL), respectively (P < .0001). Sixteen percent of the HSIL and 28% of the LSIL cases were diagnosed on repeat PS only (negative bx). If repeat PS was omitted, $21,300 would have been saved.

Publication types

  • Comparative Study
  • Evaluation Study

MeSH terms

  • Biopsy
  • Colposcopy*
  • Cost-Benefit Analysis
  • Female
  • Humans
  • Papanicolaou Test*
  • Sensitivity and Specificity
  • Uterine Cervical Dysplasia / economics
  • Uterine Cervical Dysplasia / pathology*
  • Uterine Cervical Neoplasms / economics
  • Uterine Cervical Neoplasms / pathology*
  • Vaginal Smears / economics*